Search Results for: covid-19
Articles
Quotient Sciences & CytoAgents Accelerate Potential Treatment for COVID-19 Cytokine Storm April 30, 2020
A collaboration to accelerate the development of a lead COVID-19 drug candidate into human clinical trials was recently announced today...BioAegis Demonstrates Gelsolin Therapy Can Quell the COVID-19 Cytokine Storm & Promote Tissue Repair April 29, 2020
BioAegis Therapeutics Inc. has highlighted recently published gene expression data in animal studies in which recombinant human plasma gelsolin (rhu-pGSN)...Santhera & Cold Spring Harbor Laboratory to Investigate Lonodelestat in COVID-19-Related ARDS April 29, 2020
Santhera Pharmaceuticals recently announced it has entered into a collaboration agreement with Cold Spring Harbor Laboratory (CSHL) to investigate the...Catalent Signs Agreement With Johnson & Johnson to be US Manufacturing Partner for Lead COVID-19 Vaccine Candidate April 29, 2020
Catalent, Inc. recently announced a collaboration with the Janssen Pharmaceutical Companies of Johnson & Johnson, whereby Catalent’s Biologics business unit will accelerate availability of manufacturing capacity and…
PharmaCircle’s COVID-19 Coverage is Available to Everyone April 28, 2020
Updated daily, coverage includes top line epidemiology, the current active pipeline, vaccine development, diagnostic tests, recent news and clinical trials.
Pivotal to Provide Specialized Clinical Research Services for New Clinical Trial With Patients That Have COVID-19 April 28, 2020
Pivotal recently announced it has been contracted to provide specialized clinical research services in a clinical trial to study the efficacy and safety of hyperimmune plasma, obtained from…
Q BioMed Initiates Rapid Development of Novel COVID-19 Therapeutics April 23, 2020
Q BioMed Inc. recently announced that together with its technology partner, Mannin Research, they are accelerating the rapid development of novel drugs for the treatment of life-threatening complications caused by COVID-19 and….
INmune Bio Announces Initiation of Clinical Program to Determine if Company’s Platform May Prevent Complications of Cytokine Storm Caused by COVID-19 April 23, 2020
INmune Bio, Inc. recently announced the initiation of a therapeutic program to treat patients with pulmonary complications from COVID-19 infection...Vaxart Announces Positive Preclinical Data for its Oral COVID-19 Vaccine Program April 23, 2020
Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, recently...Ascendia Joins the Fight Against COVID-19; Developing Formulations April 23, 2020
Ascendia Pharmaceuticals, a specialty CDMO company engaged in the design, formulation, optimization, and manufacture of poorly soluble molecules for various...COVID-19: Gattefossé Takes Measures & Continues to be Operational April 20, 2020
Gattefossé - provider of personal care ingredients and pharmaceutical excipients - is committed to ensuring the protection of its employees...New COVID-19 Clinical Trial Supported by Octapharma USA April 16, 2020
Octapharma USA is supporting a new investigator initiated clinical trial led by George Sakoulas, MD, of Sharp Memorial Hospital in San Diego, CA, focused on treating the most critical patients at the….
HALIX Enters Collaboration for GMP Manufacturing of a COVID-19 Vaccine April 15, 2020
HALIX B.V. has recently joined a consortium of partners under the guidance of the University of Oxford, to provide GMP manufacturing services supporting the large scale production of….
Biomarkers Heavily Used as Diagnostic Tools in COVID-19 Trials April 15, 2020
Biomarkers are a beneficial tool in the search for a COVID-19 vaccine and will help speed up clinical trials, reduce...7 Hills Pharma Announces COVID-19 Vaccine Program Targeting At-Risk Elderly April 15, 2020
7 Hills Pharma, a clinical stage immunotherapy company focused on development of drugs for the treatment and prevention of cancer...OncoSec Collaborates With Providence Cancer Institute to Conduct First-in-Human Trial of Investigational Vaccine to Prevent COVID-19 April 9, 2020
OncoSec Medical Incorporated recently announced that Providence Cancer Institute, a part of Providence St. Joseph Health, is pursuing a first-in-human Phase 1 clinical trial of OncoSec’s novel….
Leading BioSciences Announces Potential for Investigational Drug to Treat Multiple Organ Dysfunction Syndrome in COVID-19 Patients April 9, 2020
Leading BioSciences recently announced it has developed a potential approach to treat COVID-19 patients suffering from acute respiratory distress syndrome (ARDS) and multiple organ dysfunction syndrome (MODS) using its….
Cytovia Therapeutics & Macromoltek to Develop Dual-Acting Natural Killer Immunotherapy Against SARS CoV2 (COVID-19) April 9, 2020
Cytovia Therapeutics recently announced it is expanding its programs to help urgently address the current SAR CoV2 (COVID-19) crisis. Natural...Global Regulators Discuss Observational Studies of Real-World Data for COVID-19 Medicines April 9, 2020
In a recent dedicated COVID-19 workshop, organized by the European Medicines Agency (EMA) under the umbrella of the International Coalition...Novavax Identifies COVID-19 Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May April 8, 2020
Novavax, Inc. recently announced it has identified a coronavirus vaccine candidate, NVX-CoV2373, a stable, prefusion protein made using Novavax’ proprietary...
